Subscription for Prostate Cancer Newsletter | Us Too International

Us TOO Prostate Cancer NEWS You Can Use from Us TOO

 

We thankfully acknowledge the following sponsors of the
11th Annual SEA Blue Chicago Prostate Cancer Walk & Run

SEA BLUE walk


PLATINUM
Level Sponsors
image1
image1
image2
image1
GOLD
Level Sponsors
 
image1
image1
SILVER
Level Sponsors
image1
image1
image1
COPPER
Level Sponsors
Boston Scientific
Cancer Treatment
Centers of America
Home Run Inn Pizza
TOLMAR
COMMUNITY
Level Sponsors
Bank of America
Merrill Lynch
MUFG
FRIEND
Level Sponsors
Howard Simon
Janssen
Sport Clips
In-Kind
Sponsors
Hofbrauhaus
My Fit Foods
Nestle
Nesquik
 


Genomic fingerprint may predict aggressive prostate cancer in African-Americans

By a News Reporter-Staff News Editor at Cancer Weekly -- (PHILADELPHIA) -- African American men are more likely to develop prostate cancer than European American men, and are also

Prostate 'organoid' hints at how early BPA exposure may increase cancer risk

By a News Reporter-Staff News Editor at Cancer Weekly -- A first-of-its kind prostate 'organoid' grown from human embryonic stem cells has enabled researchers to show that exposure

Prostate cancer is 5 different diseases

By a News Reporter-Staff News Editor at Cancer Weekly -- Cancer Research UK scientists have for the first time identified that there are five distinct types of prostate cancer and

Prostate cancer has 5 different types, say researchers

There are five genetically distinct types of prostate cancer, researchers have found in a study, suggesting different treatments could be targeted to each patient. Researchers in

Reports Summarize Prostate Cancer Study Results from Johns Hopkins University (New Treatment Options for Patients With Metastatic Prostate Cancer:...

Reports Summarize Prostate Cancer Study Results from Johns Hopkins University (New Treatment Options for Patients With Metastatic Prostate Cancer: What Is The Optimal Sequence?) By

Simply observing men with very low- and low-risk prostate cancer very effective and underused

By a News Reporter-Staff News Editor at Cancer Weekly -- Monitoring men with very low- and low-risk prostate cancers using watchful waiting or active surveillance, called expectant

For prostate cancer patients, risk-specific therapies now more the norm

By a News Reporter-Staff News Editor at Biotech Week -- After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients

New Prostate Cancer Findings Reported from Institute for Environment (Phenotypic malignant changes and untargeted lipidomic analysis of long-term...

New Prostate Cancer Findings Reported from Institute for Environment (Phenotypic malignant changes and untargeted lipidomic analysis of long-term exposed prostate cancer cells to

New Prostate Cancer Study Findings Have Been Reported by Investigators at University Hospital (Image Guided Focal Therapy for Magnetic Resonance...

New Prostate Cancer Study Findings Have Been Reported by Investigators at University Hospital (Image Guided Focal Therapy for Magnetic Resonance Imaging Visible Prostate Cancer

Findings in the Area of Prostate Cancer Reported from University of Paris (Magnetic Resonance Imaging Targeted Biopsy Improves Selection of Patients...

Findings in the Area of Prostate Cancer Reported from University of Paris (Magnetic Resonance Imaging Targeted Biopsy Improves Selection of Patients Considered for Active

New Prostate Cancer Findings from Washington State University Described [Development of inhibitor-directed enzyme prodrug therapy (IDEPT) for...

New Prostate Cancer Findings from Washington State University Described [Development of inhibitor-directed enzyme prodrug therapy (IDEPT) for prostate cancer] By a News Reporter-

Urology Practice Publishes Study Showing Oncotype DX® Increases Use of Active Surveillance in Prostate Cancer Patients by 56 Percent

By a News Reporter-Staff News Editor at Cancer Weekly -- Genomic Health, Inc. (Nasdaq: GHDX) announced that Urology Practice published results from the second clinical utility

Reports Outline Prostate Cancer Study Results from Johns Hopkins University (Protease-Activated Pore-Forming Peptides for the Treatment and Imaging...

Reports Outline Prostate Cancer Study Results from Johns Hopkins University (Protease-Activated Pore-Forming Peptides for the Treatment and Imaging of Prostate Cancer) By a News

Researchers at Vanderbilt University Have Reported New Data on Prostate Cancer (Inhibition of NF-kappa B signaling restores responsiveness of...

Researchers at Vanderbilt University Have Reported New Data on Prostate Cancer (Inhibition of NF-kappa B signaling restores responsiveness of castrate-resistant prostate cancer

Studies from University of Occupational and Environmental Health Yield New Data on Prostate Cancer (Cessation of Primary Androgen Deprivation Therapy...

Studies from University of Occupational and Environmental Health Yield New Data on Prostate Cancer (Cessation of Primary Androgen Deprivation Therapy for Men With Localized

Reports Summarize Prostate Cancer Study Results from Johns Hopkins University (Development and Clinical Validation of an In Situ Biopsy-Based...

Reports Summarize Prostate Cancer Study Results from Johns Hopkins University (Development and Clinical Validation of an In Situ Biopsy-Based Multimarker Assay for Risk

Investigators from University of Alabama Report New Data on Prostate Cancer (Pooled Analysis of C-Reactive Protein Levels and Mortality in Prostate...

Investigators from University of Alabama Report New Data on Prostate Cancer (Pooled Analysis of C-Reactive Protein Levels and Mortality in Prostate Cancer Patients) By a News

Inovio Pharmaceuticals Initiates Clinical Trial of INO-5150 DNA Immunotherapy for Prostate Cancer

PLYMOUTH MEETING, Pa., July 27, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that it has initiated a phase I trial to evaluate Inovio's DNA

Studies from Duke University Describe New Findings in Prostate Cancer (Exploring the Clinical Benefit of Docetaxel or Enzalutamide After Disease...

Studies from Duke University Describe New Findings in Prostate Cancer (Exploring the Clinical Benefit of Docetaxel or Enzalutamide After Disease Progression During Abiraterone

New Data from Shanghai Jiao-Tong University Illuminate Findings in Prostate Cancer (In Vivo Molecular MRI Imaging of Prostate Cancer by Targeting...

New Data from Shanghai Jiao-Tong University Illuminate Findings in Prostate Cancer (In Vivo Molecular MRI Imaging of Prostate Cancer by Targeting PSMA with Polypeptide-Labeled

University of Munich Details Findings in Prostate Cancer (Role of active surveillance and focal therapy in low- and intermediate-risk prostate...

University of Munich Details Findings in Prostate Cancer (Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers) By a News Reporter-Staff

Black men are at double the risk of prostate cancer compared to white men

By a News Reporter-Staff News Editor at China Weekly News -- Black men in England are at double the lifetime risk of being diagnosed with, and dying from, prostate cancer compared

Theranostic drug personalizes prostate cancer imaging and therapy

By a News Reporter-Staff News Editor at Clinical Trials Week -- Baltimore, Md. (Embargoed until 12:30 p.m., ) - A novel radionuclide drug tackles the challenge of prostate cancer

An immune system marker for therapy-resistant prostate cancer

By a News Reporter-Staff News Editor at Cancer Weekly -- Cold Spring Harbor, N.Y. -- You are a patient who has just been treated for a serious illness but neither you nor your

PET detects more prostate cancer than conventional imaging

By a News Reporter-Staff News Editor at Clinical Trials Week -- Baltimore, Md. (embargoed until 12:30 p.m. EDT, ) - Research presented at the 2015 Annual Meeting of the Society of

Tests to gauge genetic risks for prostate cancer now are feasible

By a News Reporter-Staff News Editor at Cancer Weekly -- Men with an elevated, genetically inherited risk for prostate cancer could be routinely identified with a simple blood or

Astellas And Medivation Announce Enrollment Of The First Patients In Advanced Prostate Cancer Outcomes Registry

By a News Reporter-Staff News Editor at Cancer Weekly -- Astellas and Medivation, Inc. (NASDAQ: MDVN) announced that the first patients have been enrolled in TRUMPET (Treatment

GenomeDx's Decipher Prostate Cancer Classifier Accurately Predicts Metastasis Ten Years after Prostate Removal in Study Published by European Urology

By a News Reporter-Staff News Editor at Cancer Weekly -- GenomeDx Biosciences announced that a study published in European Urology showed that its Decipher® Prostate Cancer

Findings from Medical University Broaden Understanding of Prostate Cancer (Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite...

Findings from Medical University Broaden Understanding of Prostate Cancer (Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A

OPKO 4Kscore® Recommended in National Comprehensive Cancer Network Guidelines for Prostate Cancer Early Detection

By a News Reporter-Staff News Editor at Cancer Weekly -- OPKO Health, Inc. (NYSE:OPK) announced the decision of the National Comprehensive Cancer Network (NCCN) to include 4Kscore

Award-winning agent developed for prostate cancer diagnosis and treatment

By a News Reporter-Staff News Editor at Clinical Trials Week -- Prostate-specific membrane antigen (PSMA) is a surface protein that is normally present on healthy prostate cells

Studies from University of Texas Yield New Information about Prostate Cancer (DNA damage response and prostate cancer: defects, regulation and...

Studies from University of Texas Yield New Information about Prostate Cancer (DNA damage response and prostate cancer: defects, regulation and therapeutic implications) By a News

Reports from Wake Forest University Describe Recent Advances in Prostate Cancer (Personalized prostate cancer therapy based on systems analysis of...

Reports from Wake Forest University Describe Recent Advances in Prostate Cancer (Personalized prostate cancer therapy based on systems analysis of the apoptosis regulatory network

New Prostate Cancer Findings from University of Miami Described (Bench-to-bedside development of agonists and antagonists of luteinizing hormone...

New Prostate Cancer Findings from University of Miami Described (Bench-to-bedside development of agonists and antagonists of luteinizing hormone releasing hormone for treatment of

Studies from Montefiore Medical Center Have Provided New Information about Prostate Cancer (Managing bone metastases and reducing skeletal related...

Studies from Montefiore Medical Center Have Provided New Information about Prostate Cancer (Managing bone metastases and reducing skeletal related events in prostate cancer) By a

Vanderbilt-led study finds significant drop in new prostate cancer diagnoses

By a News Reporter-Staff News Editor at Cancer Weekly -- A new study led by Vanderbilt University Medical Center investigators found new diagnoses of prostate cancer in the U.S

Studies in the Area of Prostate Cancer Reported from University Hospital (Clinical Outcomes of Castration-resistant Prostate Cancer Treatments...

Studies in the Area of Prostate Cancer Reported from University Hospital (Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line

Data from M. Valerio and Colleagues Advance Knowledge in Prostate Cancer (Detection of Clinically Significant Prostate Cancer Using Magnetic...

Data from M. Valerio and Colleagues Advance Knowledge in Prostate Cancer (Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion

Cleveland Clinic Details Findings in Prostate Cancer (Gleason Upgrading with Time in a Large Prostate Cancer Active Surveillance Cohort)

By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on Oncology is now available. According to news reporting out of Cleveland, Ohio, by NewsRx editors, research

New Findings from Ludwig-Maximilians-University Describe Advances in Prostate Cancer (Circulating tumor cells versus objective response assessment...

New Findings from Ludwig-Maximilians-University Describe Advances in Prostate Cancer (Circulating tumor cells versus objective response assessment predicting survival in metastatic

Findings from Dana-Farber Cancer Institute in the Area of Prostate Cancer Reported (Importance of Local Control in Early-Stage Prostate Cancer:...

Findings from Dana-Farber Cancer Institute in the Area of Prostate Cancer Reported (Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive

New Clinical Oncology Findings from University of California Described (High-risk prostate cancer-classification and therapy)

By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on Oncology is now available. According to news reporting originating in San Francisco, California, by NewsRx

New Data from University of Toronto Illuminate Findings in Prostate Cancer (Risks, benefits, and approaches to hormonal blockade in prostate cancer...

New Data from University of Toronto Illuminate Findings in Prostate Cancer (Risks, benefits, and approaches to hormonal blockade in prostate cancer Highlights from the European

New Findings Reported from Ghent University Hospital Describe Advances in Prostate Cancer (Battling resistance mechanisms in antihormonal prostate...

New Findings Reported from Ghent University Hospital Describe Advances in Prostate Cancer (Battling resistance mechanisms in antihormonal prostate cancer treatment: Novel agents

Studies from Department of Surgery Have Provided New Information about Prostate Cancer (Ubiquitin-proteasomal degradation of antiapoptotic survivin...

Studies from Department of Surgery Have Provided New Information about Prostate Cancer (Ubiquitin-proteasomal degradation of antiapoptotic survivin facilitates induction of

Investigators at University of Heidelberg School of Medicine Have Reported New Data on Prostate Cancer [Evolving therapeutic concepts in prostate...

Investigators at University of Heidelberg School of Medicine Have Reported New Data on Prostate Cancer [Evolving therapeutic concepts in prostate cancer based on genome-wide

Data from Cleveland Clinic Provide New Insights into Prostate Cancer (Long-Term Efficacy and Toxicity of Low-Dose-Rate I-125 Prostate Brachytherapy...

Data from Cleveland Clinic Provide New Insights into Prostate Cancer (Long-Term Efficacy and Toxicity of Low-Dose-Rate I-125 Prostate Brachytherapy as Monotherapy in Low

Recent Findings in Prostate Cancer Described by Researchers from Fudan University (Efficacy and toxicity of molecular targeted therapies in...

Recent Findings in Prostate Cancer Described by Researchers from Fudan University (Efficacy and toxicity of molecular targeted therapies in combination with docetaxel for

Reports from Tulane University Advance Knowledge in Prostate Cancer (Aminomethylphosphonic Acid and Methoxyacetic Acid Induce Apoptosis in Prostate...

Reports from Tulane University Advance Knowledge in Prostate Cancer (Aminomethylphosphonic Acid and Methoxyacetic Acid Induce Apoptosis in Prostate Cancer Cells) By a News Reporter

Findings from University of Toronto in Prostate Cancer Reported (High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term...

Findings from University of Toronto in Prostate Cancer Reported (High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different

International study of advanced prostate cancer genome finds potential targets for drug therapy

By a News Reporter-Staff News Editor at Biotech Week -- BOSTON -- 5/20/2015 The first major effort to canvas the genomic landscape of advanced prostate cancer has revealed that

Urine-based test improves on PSA for detecting prostate cancer

By a News Reporter-Staff News Editor at Cancer Weekly -- ANN ARBOR, Mich. -- A new urine-based test improved prostate cancer detection - including detecting more aggressive forms

Recurrence of prostate cancer detected earlier with innovative PSMA-ligand PET/CT

By a News Reporter-Staff News Editor at Cancer Weekly -- A recent study reported in The Journal of Nuclear Medicine compared use of the novel Ga-68-PSMA-ligand PET/CT with other

Combined radiation and hormonal therapy improves survival in node-positive prostate cancer

By a News Reporter-Staff News Editor at Biotech Week -- A new study finds that men with prostate cancer that has spread to nearby lymph nodes, who have a significant risk of dying

Genomic Health Announces Favorable Draft Local Coverage Determination from Palmetto GBA® on Medicare Coverage for the Oncotype DX® Prostate Cancer...

Genomic Health Announces Favorable Draft Local Coverage Determination from Palmetto GBA® on Medicare Coverage for the Oncotype DX® Prostate Cancer Test By a News Reporter-Staff

Advanced viral gene therapy eradicates prostate cancer in preclinical experiments

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Even with the best available treatments, the median survival of patients with metastatic, hormone-refractory

Oncotype DX® Prostate Cancer Test Improves Risk Assessment for One in Four Men and Reduces Overall Healthcare Costs

By a News Reporter-Staff News Editor at Cancer Weekly -- Genomic Health, Inc. (Nasdaq: GHDX) announced results from three studies that show the real-world positive impact of the

Researchers at Wayne State University Report Findings in Prostate Cancer (Therapeutic options and multifaceted treatment paradigms in metastatic...

Researchers at Wayne State University Report Findings in Prostate Cancer (Therapeutic options and multifaceted treatment paradigms in metastatic castrate-resistant prostate cancer

Recent Data from C. Paterson and Co-Authors Highlight Findings in Prostate Cancer (Exploring prostate cancer survivors' self-management behaviours...

Recent Data from C. Paterson and Co-Authors Highlight Findings in Prostate Cancer (Exploring prostate cancer survivors' self-management behaviours and examining the mechanism

Findings on Prostate Cancer Reported by Investigators at Johns Hopkins University (Screening Prostate-specific Antigen Concentration and Prostate...

Findings on Prostate Cancer Reported by Investigators at Johns Hopkins University (Screening Prostate-specific Antigen Concentration and Prostate Cancer Mortality: The Korean Heart

Moffitt researchers work to determine why some prostate cancer patients experience more hot flashes

By a News Reporter-Staff News Editor at Cancer Weekly -- TAMPA, Fla. -- Androgen deprivation therapy (ADT) is a common treatment option for patients with advanced stage prostate

Researchers unveil new gene subgroup in prostate cancer

The discoveries, published online in Nature Genetics, are a further step along the road to personalizing prostate cancer medicine say study co-leads, Dr. Robert Bristow, a

Researchers focus on potential tool for predicting survival, staging prostate cancer

By a News Reporter-Staff News Editor at Cancer Weekly -- INDIANAPOLIS -- Researchers with the Indiana University School of Medicine have identified a molecule that promotes

Studies from AstraZeneca Yield New Data on Prostate Cancer (Combination AZD5363 with Enzalutamide Significantly Delays Enzalutamide-resistant...

Studies from AstraZeneca Yield New Data on Prostate Cancer (Combination AZD5363 with Enzalutamide Significantly Delays Enzalutamide-resistant Prostate Cancer in Preclinical Models

Statins associated with longer prostate cancer time to progression during ADT

By a News Reporter-Staff News Editor at Biotech Week -- The use of cholesterol-lowering statins when men initiated androgen deprivation therapy for prostate cancer was associated

New screening method for prostate cancer recurrence

By a News Reporter-Staff News Editor at Computer Weekly News -- The American Cancer Society estimated that 220,800 new cases of prostate cancer will be diagnosed in the United

DiagnoCure's new prostate cancer multimarker urine test featured at a recent press event of the American Urological Association

By a News Reporter-Staff News Editor at Cancer Weekly -- DiagnoCure Inc. (TSX: CUR; OTCQX: DGCRF) (the "Corporation") reports that the results of the prospective trial on its

Findings in Prostate Cancer Reported from Duke University (Pain, PSA flare, and bone scan response in a patient with metastatic castration-resistant...

Findings in Prostate Cancer Reported from Duke University (Pain, PSA flare, and bone scan response in a patient with metastatic castration-resistant prostate cancer treated with

Studies from CREAL Yield New Information about Prostate Cancer (A Decision Aid to Support Informed Choices for Patients Recently Diagnosed With...

Studies from CREAL Yield New Information about Prostate Cancer (A Decision Aid to Support Informed Choices for Patients Recently Diagnosed With Prostate Cancer A Randomized

Myriad validates active surveillance threshold with Prolaris® for men with prostate cancer

By a News Reporter-Staff News Editor at Clinical Trials Week -- Annual Meeting being held May 15 to 19 in New Orleans, La. The results highlighted and underscored the significant

Research Conducted at University of California Has Provided New Information about Prostate Cancer (Racial parity in tumor burden, treatment choice...

Research Conducted at University of California Has Provided New Information about Prostate Cancer (Racial parity in tumor burden, treatment choice and survival outcomes in men with

Data on Prostate Cancer Reported by Researchers at Henry Ford Hospital (Risk of Diabetes among Patients Receiving Primary Androgen Deprivation...

Data on Prostate Cancer Reported by Researchers at Henry Ford Hospital (Risk of Diabetes among Patients Receiving Primary Androgen Deprivation Therapy for Clinically Localized

Findings in Prostate Cancer Reported from Johns Hopkins University (Conditional Probability of Reclassification in an Active Surveillance Program for...

Findings in Prostate Cancer Reported from Johns Hopkins University (Conditional Probability of Reclassification in an Active Surveillance Program for Prostate Cancer) By a News

Men with asthma less likely to develop lethal prostate cancer

By a News Reporter-Staff News Editor at Clinical Trials Week -- In what they are calling a surprising finding in a large study of men who completed questionnaires and allowed

Unemployment linked to rise in prostate cancer deaths

By a News Reporter-Staff News Editor at Cancer Weekly -- The knock-on effects of the economic downturn have been explored in economy and psychology. Now researchers are examining

What drives advanced prostate cancer? New study describes genomic landscape

By a News Reporter-Staff News Editor at Biotech Week -- ANN ARBOR, Mich. -- An international collaboration of researchers are advancing precision medicine to men with advanced

Groundbreaking Research Moves One Step Closer to Personalizing Prostate Cancer Treatment

By a News Reporter-Staff News Editor at Cancer Weekly -- The results of groundbreaking genetics research in Canada, funded by the Movember Foundation, the Ontario Institute for

Researchers from National Cancer Institute Report Findings in Prostate Cancer (Dual Targeting of the Androgen Receptor and Hypoxia-Inducible Factor 1...

Researchers from National Cancer Institute Report Findings in Prostate Cancer (Dual Targeting of the Androgen Receptor and Hypoxia-Inducible Factor 1 alpha Pathways Synergistically

Reports Outline Prostate Cancer Study Findings from University of California (Adjuvant Versus Neoadjuvant Androgen Deprivation With Radiotherapy for...

Reports Outline Prostate Cancer Study Findings from University of California (Adjuvant Versus Neoadjuvant Androgen Deprivation With Radiotherapy for Prostate Cancer: Does

Reports from Department of Oncology Describe Recent Advances in Prostate Cancer (Enzalutamide After Docetaxel and Abiraterone Acetate Treatment in...

Reports from Department of Oncology Describe Recent Advances in Prostate Cancer (Enzalutamide After Docetaxel and Abiraterone Acetate Treatment in Prostate Cancer: A Pooled


Receive emails from Us TOO including the HotSheet e-newsletter and the latest Prostate Cancer News You Can Use each month.

Subscribe to the news feed and emails from Us TOO.

Click here to Subscribe